Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ALT-803
ALT-803
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
CP Wire
Fri, 04/6/18 - 12:00 am
metastatic non-small cell lung cancer
Altor Bioscience
ALT-803
Opdivo
Bristol-Myers Squibb
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
Thu, 04/5/18 - 11:40 pm
Opdivo
ALT-803
Bristol-Myers Squibb
Altor Bioscience